Article

Glaucoma drug combination offers effective IOP lowering

Fixed combination compares favorably with concomitant use of prostaglandin analogue, beta-blocker

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) Introducing iOpeners: Unpacking high-yield ophthalmology tips and clinical pearls, with Nicole Bajic, MD
Related Content
identifeye HEALTH launches retinal screening platform
August 26th 2025

identifeye HEALTH launches retinal screening platform

3 Things You Should Know About the GA Pipeline
August 26th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

OCT changes with low-level red light therapy for myopia in children
August 26th 2025

OCT changes with low-level red light therapy for myopia in children

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 26th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

Next-generation IOLs advance complex cataract care
August 26th 2025

Next-generation IOLs advance complex cataract care

Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
August 26th 2025

Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair

© 2025 MJH Life Sciences

All rights reserved.